US Physical Therapy Inc
USPHUS Physical Therapy Inc (USPH) is a provider of outpatient physical therapy services in the United States. The company focuses on rehabilitative care through a network of clinics, offering therapy for various musculoskeletal and neurological conditions. Founded in 1990, US Physical Therapy has grown through acquisitions and organic expansion, emphasizing personalized patient care and clinical excellence.
Dividend History
Investors can expect a dividend payout of $0.45 per share, scheduled to be distributed in 4 days on December 12, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 12, 2025 | $0.45 | 2025-11-17 | 2025-11-17 |
| September 12, 2025 | $0.45 | 2025-08-22 | 2025-08-22 |
| June 13, 2025 | $0.45 | 2025-05-23 | 2025-05-23 |
| April 11, 2025 | $0.45 | 2025-03-14 | 2025-03-14 |
| December 6, 2024 | $0.44 | 2024-11-15 | 2024-11-15 |
Dividends Summary
- US Physical Therapy Inc has issued 58 dividend payments over the past 14 years
- The most recent dividend was paid 87 days ago, on September 12, 2025
- The highest dividend payed out to investors during this period was $0.45 per share
- The average dividend paid during this period was $0.26 per share.
Company News
Spine & Sport Physical Therapy has been named the official physical therapy partner for the San Diego Seals professional lacrosse team for the 2025-2026 season, providing comprehensive sports medicine services including injury prevention and rehabilitation.
U.S. Physical Therapy reported Q2 2025 earnings with mixed results, missing analyst expectations on EPS and revenue, but achieving record patient volumes and strong industrial injury prevention segment growth. The company raised full-year EBITDA guidance and continued its acquisition strategy.
Stocks opened lower as geopolitical tensions in the Middle East escalated, driving up oil prices and Treasury yields. The energy sector outperformed, while other sectors declined. Concerns over potential Israeli retaliation against Iran and the ongoing war in Gaza weighed on the market.
With earnings estimate revisions on the rise for these top medical stocks, they certainly shouldn't be overlooked given their blazing historical performances.
